Pulse Biosciences Stock Price, News & Analysis (NASDAQ:PLSE)

$25.94 1.07 (4.30 %)
(As of 11/21/2017 02:55 AM ET)
Previous Close$24.87
Today's Range$24.80 - $26.90
52-Week Range$5.20 - $39.50
Volume100,400 shs
Average Volume279,420 shs
Market Capitalization$406.41 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Pulse Biosciences (NASDAQ:PLSE)

Pulse Biosciences logoPulse Biosciences, Inc., formerly Electroblate, Inc., is a development-stage medical device company using a platform technology called Nano-Pulse Electro-Signaling (NPES). NPES is a local and drug-free technology that utilizes nanosecond pulsed electric fields to induce cell signaling and the activation of cellular pathways in tissue. NPES provides treatment in a range of dermatology and aesthetic applications. It offers treatment for minimally invasive applications, such as cardiac ablation, lung disease, Barret's esophagus, thyroid nodules, and ear, nose and throat (ENT) papillomas. The Company is developing a system for the delivery of NPES treatments, identified as the PulseTx system (PulseTx). The PulseTx system delivers NPES pulses through its tunable pulse generator and its planned suite of electrodes. The PulseTx system pulses are applied directly to tissue through electrodes, creating transient nanometer pores in cell and organelle membranes.


Industry, Sector and Symbol:
  • Industry: Advanced Medical Equipment & Technology
  • Sub-Industry: N/A
  • Sector: Healthcare
  • Symbol: NASDAQ:PLSE
  • CUSIP: N/A
  • Web: www.pulsebiosciences.com
Debt:
  • Current Ratio: 17.23%
  • Quick Ratio: 17.23%
Sales & Book Value:
  • Annual Sales: N/A
  • Price / Sales: N/A
  • Book Value: $1.90 per share
  • Price / Book: 13.65
Profitability:
  • Trailing EPS: ($1.40)
  • Net Income: $-9,510,000.00
  • Return on Equity: -62.10%
  • Return on Assets: -57.47%
Misc:
  • Employees: 13
  • Outstanding Shares: 16,340,000
 

Frequently Asked Questions for Pulse Biosciences (NASDAQ:PLSE)

What is Pulse Biosciences' stock symbol?

Pulse Biosciences trades on the NASDAQ under the ticker symbol "PLSE."

How were Pulse Biosciences' earnings last quarter?

Pulse Biosciences, Inc (NASDAQ:PLSE) issued its quarterly earnings results on Tuesday, November, 7th. The company reported ($0.52) EPS for the quarter. View Pulse Biosciences' Earnings History.

Who are some of Pulse Biosciences' key competitors?

When did Pulse Biosciences IPO?

(PLSE) raised $20 million in an initial public offering (IPO) on Wednesday, May 18th 2016. The company issued 5,000,000 shares at a price of $4.00 per share. MDB Capital Group and Feltl and Company served as the underwriters for the IPO.

Who owns Pulse Biosciences stock?

Pulse Biosciences' stock is owned by a number of of retail and institutional investors. Top institutional investors include DUGGAN ROBERT W (35.70%), DUGGAN ROBERT W (26.70%), Wells Fargo & Company MN (0.43%), Bank of New York Mellon Corp (0.39%) and Tocqueville Asset Management L.P. (0.14%). Company insiders that own Pulse Biosciences stock include Maky Zanganeh, Mitchell E Levinson, Robert J Greenberg, Robert W Duggan and Thierry B Thaure. View Institutional Ownership Trends for Pulse Biosciences.

Who bought Pulse Biosciences stock? Who is buying Pulse Biosciences stock?

Pulse Biosciences' stock was bought by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Tocqueville Asset Management L.P. and Wells Fargo & Company MN. Company insiders that have bought Pulse Biosciences stock in the last two years include Maky Zanganeh, Mitchell E Levinson and Robert W Duggan. View Insider Buying and Selling for Pulse Biosciences.

How do I buy Pulse Biosciences stock?

Shares of Pulse Biosciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Pulse Biosciences' stock price today?

One share of Pulse Biosciences stock can currently be purchased for approximately $25.94.

How big of a company is Pulse Biosciences?

Pulse Biosciences has a market capitalization of $406.41 million. The company earns $-9,510,000.00 in net income (profit) each year or ($1.40) on an earnings per share basis. Pulse Biosciences employs 13 workers across the globe.

How can I contact Pulse Biosciences?

Pulse Biosciences' mailing address is 3957 Point Eden Way, HAYWARD, CA 94545-3720, United States. The company can be reached via phone at +1-510-9064600 or via email at ir@pulsebiosciences.com.


MarketBeat Community Rating for Pulse Biosciences (NASDAQ PLSE)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  53 (Vote Outperform)
Underperform Votes:  52 (Vote Underperform)
Total Votes:  105
MarketBeat's community ratings are surveys of what our community members think about Pulse Biosciences and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Pulse Biosciences (NASDAQ:PLSE)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 0 Hold Ratings, 0 Buy Ratings, 0 Strong Buy RatingsNo ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Analysts' Consensus Price Target: N/A

Consensus Price Target History for Pulse Biosciences (NASDAQ:PLSE)

Price Target History for Pulse Biosciences (NASDAQ:PLSE)

Analysts' Ratings History for Pulse Biosciences (NASDAQ:PLSE)

Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History and Estimates Chart for Pulse Biosciences (NASDAQ:PLSE)

Earnings by Quarter for Pulse Biosciences (NASDAQ:PLSE)

Earnings History by Quarter for Pulse Biosciences (NASDAQ PLSE)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/7/2017Q3 2017($0.52)ViewN/AView Earnings Details
7/27/2017Q2 2017($0.43)ViewN/AView Earnings Details
5/4/2017Q2 2017($0.23)ViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Pulse Biosciences (NASDAQ:PLSE)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Pulse Biosciences (NASDAQ:PLSE)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Pulse Biosciences (NASDAQ PLSE)

Insider Ownership Percentage: 6.70%
Institutional Ownership Percentage: 8.53%
Insider Trades by Quarter for Pulse Biosciences (NASDAQ:PLSE)
Institutional Ownership by Quarter for Pulse Biosciences (NASDAQ:PLSE)

Insider Trades by Quarter for Pulse Biosciences (NASDAQ PLSE)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/19/2017Robert W DugganMajor ShareholderBuy22,901$22.79$521,913.79View SEC Filing  
9/24/2017Robert W DugganMajor ShareholderBuy2,000,000$15.02$30,040,000.00View SEC Filing  
9/18/2017Maky ZanganehDirectorBuy29,775$13.36$397,794.00View SEC Filing  
9/18/2017Robert W DugganMajor ShareholderBuy409,918$14.36$5,886,422.48View SEC Filing  
9/14/2017Mitchell E LevinsonDirectorBuy3,835$12.30$47,170.50View SEC Filing  
8/3/2017Maky ZanganehDirectorBuy28,790$23.96$689,808.40View SEC Filing  
8/3/2017Robert W DugganMajor ShareholderBuy277,450$23.14$6,420,193.00View SEC Filing  
8/2/2017Maky ZanganehDirectorBuy8,290$25.15$208,493.50View SEC Filing  
5/23/2017Robert W DugganMajor ShareholderBuy83,928$26.86$2,254,306.08View SEC Filing  
5/22/2017Robert W DugganMajor ShareholderBuy34,728$26.25$911,610.00View SEC Filing  
5/12/2017Thierry B ThaureDirectorSell10,000$24.40$244,000.00View SEC Filing  
5/11/2017Robert W DugganMajor ShareholderBuy43,389$21.04$912,904.56View SEC Filing  
5/10/2017Robert J GreenbergDirectorSell25,000$21.12$528,000.00View SEC Filing  
5/8/2017Thierry B ThaureDirectorSell15,000$22.49$337,350.00View SEC Filing  
4/28/2017Robert W DugganMajor ShareholderBuy84,348$23.88$2,014,230.24View SEC Filing  
4/27/2017Robert W DugganMajor ShareholderBuy35,387$24.79$877,243.73View SEC Filing  
4/19/2017Robert W DugganMajor ShareholderBuy150,123$23.77$3,568,423.71View SEC Filing  
4/18/2017Robert W DugganMajor ShareholderBuy61,819$25.49$1,575,766.31View SEC Filing  
4/17/2017Robert W DugganMajor ShareholderBuy107,300$24.81$2,662,113.00View SEC Filing  
4/10/2017Robert W. DugganMajor ShareholderBuy191,464$19.75$3,781,414.00View SEC Filing  
3/20/2017Maky ZanganehDirectorBuy18,240$23.34$425,721.60View SEC Filing  
3/18/2017Robert W DugganMajor ShareholderBuy205,127$23.56$4,832,792.12View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Pulse Biosciences (NASDAQ PLSE)

Source:
DateHeadline
Pulse Biosciences Quarterly Investor Conference Call - Business Wire (press release)Pulse Biosciences Quarterly Investor Conference Call - Business Wire (press release)
www.businesswire.com - November 9 at 11:39 AM
Pulse Biosciences, Inc. to Host Earnings CallPulse Biosciences, Inc. to Host Earnings Call
finance.yahoo.com - November 9 at 11:39 AM
Pulse Biosciences Quarterly Investor Conference CallPulse Biosciences Quarterly Investor Conference Call
finance.yahoo.com - November 9 at 11:39 AM
Pulse Biosciences, Inc (PLSE) Issues Quarterly  Earnings ResultsPulse Biosciences, Inc (PLSE) Issues Quarterly Earnings Results
www.americanbankingnews.com - November 8 at 3:02 PM
Pulse Biosciences, Inc (PLSE) to Release Earnings on MondayPulse Biosciences, Inc (PLSE) to Release Earnings on Monday
www.americanbankingnews.com - November 6 at 2:14 AM
Pulse Biosciences to Host Quarterly Investor Conference Call on November 7, 2017Pulse Biosciences to Host Quarterly Investor Conference Call on November 7, 2017
finance.yahoo.com - October 25 at 9:10 AM
Commit To Purchase Pulse Biosciences At $17.50, Earn 17.5% Annualized Using Options - TheStreet.comCommit To Purchase Pulse Biosciences At $17.50, Earn 17.5% Annualized Using Options - TheStreet.com
www.thestreet.com - October 24 at 8:36 AM
Insider Buying: Pulse Biosciences, Inc (PLSE) Major Shareholder Buys 22,901 Shares of StockInsider Buying: Pulse Biosciences, Inc (PLSE) Major Shareholder Buys 22,901 Shares of Stock
www.americanbankingnews.com - October 23 at 7:28 PM
Four Tampa Bay billionaires make the Forbes 400Four Tampa Bay billionaires make the Forbes 400
www.bizjournals.com - October 19 at 7:35 AM
Healthcare Industry Trends And Its Impact On Pulse Biosciences Inc (PLSE)Healthcare Industry Trends And Its Impact On Pulse Biosciences Inc (PLSE)
finance.yahoo.com - October 16 at 2:31 AM
Tracking Pre-Clinical Data in Biotech: Risk Versus Reward - PR Newswire (press release)Tracking Pre-Clinical Data in Biotech: Risk Versus Reward - PR Newswire (press release)
www.prnewswire.com - October 5 at 9:39 PM
Pulse Biosciences (PLSE) Reports $30M Private Placement of Common StockPulse Biosciences (PLSE) Reports $30M Private Placement of Common Stock
www.streetinsider.com - September 27 at 6:00 PM
Pulse Biosciences, Inc (PLSE) Major Shareholder Purchases $30,040,000.00 in StockPulse Biosciences, Inc (PLSE) Major Shareholder Purchases $30,040,000.00 in Stock
www.americanbankingnews.com - September 26 at 7:24 PM
Mid-Afternoon Market Update: Crude Oil Up Over 3%; AZZ Shares Plummet - BenzingaMid-Afternoon Market Update: Crude Oil Up Over 3%; AZZ Shares Plummet - Benzinga
www.benzinga.com - September 25 at 5:11 PM
Pulse Biosciences (PLSE) Reports $30M Private Placement of Common Stock - StreetInsider.comPulse Biosciences (PLSE) Reports $30M Private Placement of Common Stock - StreetInsider.com
www.streetinsider.com - September 25 at 5:11 PM
Pulse Biosciences Announces $30 Million Private PlacementPulse Biosciences Announces $30 Million Private Placement
finance.yahoo.com - September 25 at 11:45 AM
Pulse Biosciences, Inc (PLSE) Major Shareholder Acquires $5,886,422.48 in StockPulse Biosciences, Inc (PLSE) Major Shareholder Acquires $5,886,422.48 in Stock
www.americanbankingnews.com - September 19 at 7:26 AM
Pulse Biosciences, Inc (PLSE) Director Maky Zanganeh Buys 29,775 SharesPulse Biosciences, Inc (PLSE) Director Maky Zanganeh Buys 29,775 Shares
www.americanbankingnews.com - September 18 at 10:26 PM
Mitchell E. Levinson Purchases 3,835 Shares of Pulse Biosciences, Inc (PLSE) StockMitchell E. Levinson Purchases 3,835 Shares of Pulse Biosciences, Inc (PLSE) Stock
www.americanbankingnews.com - September 18 at 10:26 PM
Pulse Biosciences Announces Withdrawal and Planned Resubmission of 510(k) Application for the PulseTxTM SystemPulse Biosciences Announces Withdrawal and Planned Resubmission of 510(k) Application for the PulseTxTM System
finance.yahoo.com - September 13 at 7:50 AM
Mid-Day Market Update: Dow Up 1%; Achillion Pharmaceuticals Shares PlungeMid-Day Market Update: Dow Up 1%; Achillion Pharmaceuticals Shares Plunge
www.benzinga.com - September 12 at 8:39 AM
Bloomberg Markets: Dave Wilson’s Stock of the Day for Sept. 11Bloomberg Markets: Dave Wilson’s Stock of the Day for Sept. 11
www.bloomberg.com - September 12 at 8:39 AM
Oversold Conditions For Pulse Biosciences (PLSE)Oversold Conditions For Pulse Biosciences (PLSE)
www.thestreet.com - September 12 at 8:39 AM
Pulse Biosciences Inc. (PLSE) Has Tumbled To A 6-Month LowPulse Biosciences Inc. (PLSE) Has Tumbled To A 6-Month Low
www.nasdaq.com - September 12 at 8:39 AM
Pulse Biosciences, Inc. (PLSE) Announces Withdrawal, Planned Resubmission of 510(k) Application for the PulseTx SystemPulse Biosciences, Inc. (PLSE) Announces Withdrawal, Planned Resubmission of 510(k) Application for the PulseTx System
www.streetinsider.com - September 12 at 8:39 AM
Pulse Biosciences Inc. (PLSE) Sank After Application WithdrawnPulse Biosciences Inc. (PLSE) Sank After Application Withdrawn
www.rttnews.com - September 12 at 8:39 AM
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Pulse Biosciences, Inc. (PLSE)SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Pulse Biosciences, Inc. (PLSE)
finance.yahoo.com - September 12 at 8:38 AM
Glancy Prongay & Murray LLP Commences Investigation on Behalf of Pulse Biosciences, Inc. Investors (PLSE)Glancy Prongay & Murray LLP Commences Investigation on Behalf of Pulse Biosciences, Inc. Investors (PLSE)
finance.yahoo.com - September 12 at 8:38 AM
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Pulse Biosciences, Inc.SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Pulse Biosciences, Inc.
finance.yahoo.com - September 12 at 8:38 AM
Insider Buying: Pulse Biosciences, Inc (PLSE) Director Acquires 8,290 Shares of StockInsider Buying: Pulse Biosciences, Inc (PLSE) Director Acquires 8,290 Shares of Stock
www.americanbankingnews.com - August 4 at 8:40 PM
Insider Buying: Pulse Biosciences, Inc (PLSE) Director Acquires 28,790 Shares of StockInsider Buying: Pulse Biosciences, Inc (PLSE) Director Acquires 28,790 Shares of Stock
www.americanbankingnews.com - August 4 at 7:52 PM
Robert W. Duggan Purchases 277,450 Shares of Pulse Biosciences, Inc (PLSE) StockRobert W. Duggan Purchases 277,450 Shares of Pulse Biosciences, Inc (PLSE) Stock
www.americanbankingnews.com - August 3 at 10:38 PM
Pulse Biosciences: Who Was In That Room?Pulse Biosciences: Who Was In That Room?
seekingalpha.com - August 1 at 4:28 PM
Pulse Biosciences, Inc (PLSE) Releases Quarterly  Earnings ResultsPulse Biosciences, Inc (PLSE) Releases Quarterly Earnings Results
www.americanbankingnews.com - July 28 at 6:58 PM
Pulse Biosciences Quarterly Investor and Analyst Conference Call - Business Wire (press release)Pulse Biosciences Quarterly Investor and Analyst Conference Call - Business Wire (press release)
www.businesswire.com - July 28 at 6:51 AM
Pulse Biosciences Quarterly Investor and Analyst Conference CallPulse Biosciences Quarterly Investor and Analyst Conference Call
finance.yahoo.com - July 28 at 6:51 AM
Pulse Biosciences to Host Quarterly Investor Conference Call on July 27, 2017 - Business Wire (press release)Pulse Biosciences to Host Quarterly Investor Conference Call on July 27, 2017 - Business Wire (press release)
www.businesswire.com - July 13 at 8:01 AM
Pulse Biosciences to Host Quarterly Investor Conference Call on July 27, 2017Pulse Biosciences to Host Quarterly Investor Conference Call on July 27, 2017
finance.yahoo.com - July 12 at 7:01 AM
Pulse Biosciences Announces Treatment of First Patient in Study to Evaluate the Safety and Efficacy of Novel Nano ... - Business Wire (press release)Pulse Biosciences Announces Treatment of First Patient in Study to Evaluate the Safety and Efficacy of Novel Nano ... - Business Wire (press release)
www.businesswire.com - June 8 at 12:11 AM
Form 4 Pulse Biosciences, Inc. For: May 10 Filed by: Greenberg Robert J.Form 4 Pulse Biosciences, Inc. For: May 10 Filed by: Greenberg Robert J.
www.streetinsider.com - May 12 at 12:43 AM
Kerrisdale Capital Issues Negative Report on Pulse Biosciences, Inc. and Announces Conference CallKerrisdale Capital Issues Negative Report on Pulse Biosciences, Inc. and Announces Conference Call
www.bizjournals.com - May 9 at 11:04 AM
Pulse Biosciences, Inc.: High-Voltage Hype Set To Short-CircuitPulse Biosciences, Inc.: High-Voltage Hype Set To Short-Circuit
seekingalpha.com - May 9 at 11:04 AM
PULSE BIOSCIENCES, INC. Files SEC form 10-K, Annual ReportPULSE BIOSCIENCES, INC. Files SEC form 10-K, Annual Report
biz.yahoo.com - March 21 at 10:55 AM
Q4 2016 Pulse Biosciences Inc Earnings Release - Time Not SuppliedQ4 2016 Pulse Biosciences Inc Earnings Release - Time Not Supplied
us.rd.yahoo.com - March 15 at 7:28 PM
Pulse Biosciences, Inc. (PLSE) Submits PulseTx System for FDA 510(k) ApplicationPulse Biosciences, Inc. (PLSE) Submits PulseTx System for FDA 510(k) Application
www.streetinsider.com - March 14 at 11:47 PM
PULSE BIOSCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EPULSE BIOSCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E
biz.yahoo.com - March 14 at 6:45 PM
Pulse Biosciences Inc Earnings Call scheduled for 4:30 pm ET todayPulse Biosciences Inc Earnings Call scheduled for 4:30 pm ET today
biz.yahoo.com - March 14 at 6:45 PM
BRIEF-Pulse Biosciences submits 510(k) application to FDA for Pulsetx SystemBRIEF-Pulse Biosciences submits 510(k) application to FDA for Pulsetx System
www.reuters.com - March 14 at 10:14 AM
Pulse Biosciences Inc. (PLSE) Has Climbed To Another New HighPulse Biosciences Inc. (PLSE) Has Climbed To Another New High
www.nasdaq.com - March 13 at 6:58 PM
BRIEF-Robert Duggan reports 15.4 pct stake in Pulse BiosciencesBRIEF-Robert Duggan reports 15.4 pct stake in Pulse Biosciences
www.reuters.com - February 22 at 9:18 AM

Social Media

Financials

Chart

Pulse Biosciences (NASDAQ PLSE) Chart for Tuesday, November, 21, 2017
Loading chart…

This page was last updated on 11/21/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.